ACAAI 2012 Annual Scientific Meeting (DVD) EXT

This is the online/dvd version of the 2012 ACAAI Annual Scientific Meeting.

Accreditation & Designation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 27.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

  • All practicing allergists/immunologists
  • Fellows in allergy/immunology training programs
  • Primary care physicians who care for allergy patients
  • Allied health professionals in the field of allergy and immunology

Learning Objectives

  • Identify major advances in key areas of cutting edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of the upper airways, lungs, eyes, skin and gastrointestinal tract
  • Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency
  • Translate emerging clinical science principles to clinical practice in patients with allergic and immunologicdiseases
  • Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergicand immunologic diseases
  • Explain the impact of environmental exposures and external influences on patients with allergic disorders
  • Recognize emerging trends in the prevalence of allergicand immunologic disorders and discuss their impact on public health
  • Evaluate the impact of new diagnostic and therapeuticstrategies on healthcare costs and outcomes
  • Discuss processes, tools and technologies for the efficient allergy and immunology practice
Additional information
Disclosure: 

Disclosure:

Course summary
Course opens: 
10/15/2013
Course expires: 
10/14/2015
Cost:
$0.00
Rating: 
0

All identified conflicts of interest have been resolved.

 Grant Anhalt, PhD
Consultant/Advisory Board: GlaxoSmithKline

Noga Askenazi, MD FACAAI
Stock: Johnson and Johnson

Amal Assa'ad, MD, FACAAI
Consultant/Advisory Board: Mead Johnson; Research Grant: DBV Technologies, Genentech, GlaxoSmithKline, Teva

Leonard Bacharier, MD, FACAAI
Consultant/Advisory Board: DVB Technologies, Merck, Teva; Speaker: Aerocrine, GlaxoSmithKline, Merck

Sami L. Bahna, MD, DrPH, FACAAI
Consultant/Advisory Board: Abbott; Speaker: Abbott; Honorarium: Abbott

Gregory Bensch, MD, FACAAI
Consultant, Speaker: Teva; Speaker: AstraZeneca.

William E. Berger, MD, MBA, FACAAI
Consultant/Advisory Board: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Speaker: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Honorarium: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Research Grant: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva

Jonathan A. Bernstein, MD, FACAAI
Consultant/Advisory Board: CSL Behring, Dyax, Meda, Shire, ViroPharma; Speaker: CSL Behring, Dyax, Meda, Shire, Teva, ViroPharma; Honorarium: CSL Behring, Dyax, Meda, Shire, Teva, Viropharma; Research Grant: CSL Behring, Dyax, Novartis, Shire, ViroPharma

Leonard Bielory, MD, FACAAI
Consultant/Advisory Board: Allergan, Bausch & Lomb, Merck, Pharmacal, Sanofi-Chattem; Speaker: Allergan, Bausch & Lomb, Merck; Honorarium: Allergan, Bausch & Lomb, Merck; Research Grant: Allergan, EPA; Stock: STARxTech

Clifton O. Bingham, III, MD
Consultant/Advisory Board: Abbvie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Roche, Janssen, Novartis, Novo Nordisk, Pfizer, UCB; Research Grant: Bristol-Myers Squibb, Janssen, UCB

Michael S. Blaiss, MD, FACAAI
Consultant/Advisory Board: Alcon, Allergan, Bausch & Lomb, Genentech, GlaxoSmithKline, JDP Therapeutics, Merck, Mylan, Pfizer, PMD Healthcare, Proctor & Gamble, Sanofi, Sunovion, Takeda, Teva; Speaker: Alcon, Allergan, AstraZeneca, Bausch & Lomb, Genentech, GlaxoSmithKline, Merck, Sunovion, Takeda

Don A. Bukstein, MD, FACAAI
Speaker: Aerocrine, AstraZeneca, Genentech, Merck, Novartis, Sunovion, Teva

A. Wesley Burks, MD, FACAAI
Consultant/Advisory Board: Dow AgroSciences, ExploraMed Development, Genalyte, Hycor, Mastcell Pharma, Merck, Nordic Biotech, Novartis, Perrigo Company, Regeneron, Unilever; Speaker: Mylan Specialty; Research Grant: Hycor; Stock: Allertein, Mylan Specialty

Peter A. Calabresi, MD
Consultant/Advisory Board:  Abbott, Vertex; Honorarium: Abbott, Vertex; Research Grant: Abbott, Bayer, Biogen Idec, Novartis, Vertex

Warner W. Carr, MD, FACAAI
Consultant/Advisory Board: Alcon, Allergan, Indegene, Meda; Speaker: Alcon, AstraZeneca, Meda, Teva; Honorarium: Alcon, Allergan, AstraZeneca, Indegene, Meda, Teva; Research Grant: Adrea, Forest, Sunovion

Thomas B. Casale, MD, FACAAI
Consultant/Advisory Board: Genentech, Novartis

Adrian M. Casillas, MD, FACAAI
Research Grant: CSL Behring

Bradley E. Chipps, MD, FACAAI
Consultant/Advisory Board: AstraZeneca, Mylan Specialty, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion; Speaker: AstraZeneca, Bausch & Lomb, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion; Honorarium: AstraZeneca, Bausch & Lomb, Mylan Specialty, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion

Mark L. Corbett, MD, FACAAI
Speaker: AstraZeneca, Merck, Sunovion, Teva

Linda Cox, MD, FACAAI
Consultant/Advisory Board: Genentech, Stallergenes; Speaker: Stallergenes

Timothy M Craig, DO, FACAAI
Consultant/Advisory Board: CSL Behring, Dyax. Merck; Speaker: CSL Behring, Dyax, Genentech/Novartis, Merck, Shire, ViroPharma; Honorarium: CSL Behring, Dyax, Genentech/Novartis, Merck, Shire, ViroPharma; Research Grant: CSL Behring, Dyax, Genentech/Novartis, GlaxoSmithKline, Merck, Pharming, Shire, ViroPharma

Peter S. Creticos, MD
Consultant/Advisory Board: Circassia, Greer, Merck; Research Grant: Circassia, Greer, Merck

Chitra Dinakar, MD, FACCAI
Speaker: Aerocrine, Teva; Honorarium: Aerocrine, Teva

Paul Dowling, MD, FACAAI
Speaker: Research Grant: GlaxoSmithKline, Merck

Mark S. Dykewicz, MD, FACAAI
Consultant/Advisory Board: Merck; Honorarium: Merck

Daniel Ein, MD, FACAAI
Consultant/Advisory Board: Allergan

Renata Engler, MD, FACAAI
Research Grant: National Institutes of Health, Stock: Stellar Biotech

Stanley M. Fineman, MD, MBA, FACAAI
Speaker: AstraZeneca, Genentech/Novartis, Sunovion; Research Grant: Genentech/Novartis, Shionogi, Sunovion

Michael B. Foggs, MD, FACAAI
Consultant/Advisory Board: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Merck; Speaker: AstraZeneca, GlaxoSmithKline, Merck; Honorarium: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Merck

Luz S. Fonacier, MD, FACAAI
Speaker: Baxter; Honorarium: Genentech; Research Grant: Baxter, Dyax, Genentech, Merck

Pinkus Goldberg, FACAAI
Consultant/Advisory Board: Allergan; Speaker: Genentech, Meda, Merck, Mylan, Novartis; Research Grant: Circassia, Genentech, GlaxoSmithKline, Meda, Merck, Novartis, Teva 

Richard G. Gower, MD, FACAAI
Consultant/Advisory Board: Bausch & Lomb, CSL Behring, Mylan Specialty, Dyax, Genentech, HollisterStier, Mylan, Novartis, Roche, Sanofi, Shire, Teva, ViroPharma; Speaker: Bausch & Lomb, CSL Behring, Mylan, Genentech, Novartis, Roche, Shire, Teva, ViroPharma; Honorarium: Bausch & Lomb, CSL Behring, Genentech, Mylan, Novartis, Roche, Shire, Teva, ViroPharma; Research Grant: Bausch & Lomb, Boehringer Ingelheim, Circassia,  CSL Behring, Eli Lilly, Genentech, GlaxoSmithKline, Green Cross, Kedrion, Mylan, Novartis, Pharming, Roche, Shire, Teva, ViroPharma; Stock: Merck

Matthew Greenhawt, MD, MBA, MSc
Consultant/Advisory Board: Nutricia; Research Grant: National Institutes of Health; Speaker: Nutricia; Honorarium: Nutricia

Vivian Hernandez-Trujillo, MD, FACAAI
Consultant/Advisory Board: Baxter, Merck, Sanofi; Speaker: Baxter, CSL Behring, Merck, Sanofi

Lewis Kanter, MD, FACAAI
Speaker: Alcon, Meda, Sunovion, Teva

Rohit K. Katial, MD, FACAAI
Consultant/Advisory Board: Teva; Honorarium: Teva

David A. Khan, MD, FACAAI
Speaker: Baxter, Genentech, Merck, ViroPharma; Honorarium: Baxter, Genentech, Merck, ViroPharma

Monica Kraft, MD
Research Grant: Boston Scientific, Eumedics, Genentech, GlaxoSmithKline, Merck, National Institutes of Health, Novartis

Charles J. Lane, MD
Speaker: GlaxoSmithKline; Honorarium: Mylan Specialty

Bobby Q. Lanier, MD, FACAAI
Consultant/Advisory Board: Merck, Novartis; Speaker: Merck, Novartis; Research Grant: Teva

James T. Li, MD, PhD, FACAAI
Stocks: Abbott, Johnson & Johnson, Novartis

Phillip L. Lieberman, MD, FACAAI
Consultant/Advisory Board: Meda, Mylan, Sanofi; Speaker: Meda, Mylan; Honorarium: Meda, Mylan

Todd A. Mahr, MD, FACAAI
Consultant/Advisory Board: Mylan, Sanofi; Speaker: Aerocrine, Genentech, GlaxoSmithKline, Mylan, Sanofi; Honorarium: Aerocrine, Genentech, GlaxoSmithKline, Mylan, Sanofi

Lyndon Mansfield, MD, FACAAI
Consultant/Advisory Board: Genentech; Speaker: Sunovion, Teva

Gailen D. Marshall, Jr., MD, PhD, FACP, FACAAI
Research Grant: Teva, National Institutes of Health, Health Resources and Services Administration

Kevin P. McGrath, MD, FACAAI
Speaker: Sunovion

Travis A. Miller, MD, FACAAI
Consultant/Advisory Board: Meda, Sunovion; Speaker: Alcon, AstraZeneca, Bausch & Lomb, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Sunovion, Teva; Honorarium: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Sunovion; Teva

Anthony Montanaro, MD, FACAAI
Research Grant: Boehringer Ingelheim, Genentech, GlaxoSmithKline, Merck, Novartis, Teva

Harold S. Nelson, MD, FACAAI
Consultant/Advisory Board: Merck, Shionogi: Honorarium: Merck, Pearl, Shionogi; Research Grant: Circassia, Lincoln Diagnostics, Rigel

Talal M. Nsouli, MD, FACAAI
Consultant/Advisory Board: Thermo Fisher Scientific, Sunovion, Teva; Speaker: Thermo Fisher Scientific, Sunovion, Teva

John J. Oppenheimer, MD, FACAAI
Consultant/Advisory Board: AstraZeneca, GlaxoSmithKline, Mylan, Sunovion; Research Grant: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline

Nancy K. Ostrom, MD, FACAAI
Consultant/Advisory Board: Bausch & Lomb, Meda, Merck, Teva; Speaker: AstraZeneca, GlaxoSmithKline, Meda, Merck, Novartis, Sunovion, Teva; Research Grant: Apotex, AstraZeneca, Boehringer Ingelheim, ElectroCore, GlaxoSmithKline, MedImmune, Merck, Nestle, Novartis, Rigel, Sunovion, Teva, Actavis

Thomas A.E. Platts-Mills, MD, PhD, FACAAI
Consultant/Advisory Board: ViraCor-IBT, Speaker: ALK-Abello; Honorarium: ALK-Abello, Thermo Fisher Scientific; Research Grant: Thermo Fisher Scientific

Jay M. Portnoy, MD, FACAAI
Consultant/Advisory Board: Sanofi, Thermo Fisher Scientific; Speaker: Mylan, Thermo Fisher Scientific; Honorarium: Mylan, Sanofi, Thermo Fisher Scientific

Marc A. Riedl, MD, MS
Consultant/Advisory Board: BioCryst, CSL Behring, Dyax, Shire, ViroPharma; Speaker: CSL Behring, Dyax, Shire, ViroPharma; Research Grant: CSL Behring, Dyax, Shire, ViroPharma

Ketan Sheth, MD, MBA, FACAAI
Consultant/Advisory Board: Teva; Speaker: GlaxoSmithKline, Teva; Honorarium: GlaxoSmithKline, Teva; Stocks: Merck

Charles J. Siegel, MD, FACAAI
Consultant/Advisory Board: Meda, Teva; Speaker: Meda, Teva; Honorarium: Meda, Mylan, Teva

David P. Skoner, MD, FACAAI
Consultant/Advisory Board: Bausch & Lomb, Merck, Sunovion; Speaker: GlaxoSmithKline, Merck, Novartis, Sunovion, Teva; Research Grant: GlaxoSmithKline, Greer, Merck, Novartis, Teva

Brett E. Stanaland, MD, MS, FACAAI
Consultant/Advisory Board: Sunovion, Teva; Speaker: Meda, Merck, Sunovion, Teva

Gary C. Steven, MD, PhD, FACAAI
Speaker: Merck, Novartis, Teva; Research Grant: Merck, AstraZeneca, Circassia, Genentech, Mylan, Novartis, Novum, Optinose, Concentric, Pulmagen, GlaxoSmithKline, Teva

James L. Sublett, MD, FACAAI
Consultant/Advisory Board: Aerocrine, GlaxoSmithKline, Meda, Merck, Sunovion, Teva; Speaker: GlaxoSmithKline, Merck, Sunovion, Teva; Honorarium: GlaxoSmithKline, Merck, Sunovion, Teva; Research Grant: GlaxoSmithKline, Merck, Novartis, Sunovion, Teva, 

Stanley J. Szefler, MD, FACAAI
Consultant/Advisory Board: Boehringer Ingelheim, GlaxoSmithKline, Merck, Roche; Speaker: Merck; Honorarium: Genentech; Research Grant: Boehringer Ingelheim, GlaxoSmithKline

Stephen A. Tilles, MD FACAAI
Consultant/Advisory Board: Bausch & Lomb, Hycor, Merck, Mylan, Sunovion

Janna M. Tuck, MD, FACAAI
Stocks: Advanced Cell Technology, Cel-Sci, Synergy

Dana V. Wallace, MD, FACAAI
Consultant/Advisory Board: Bausch & Lomb, Mylan, Sanofi, Sunovion, Teva

Richard W. Weber, MD, FACAAI
Consultant/Advisory Board: Genentech; Speaker: Merck; Research Grant: Novartis

The following have no relevant financial relationships to disclose:
Joseph A. Bellanti, MD, FACAAI
Monica Bhagat, MD
Christina Ciaccio, MD, FACAAI
John O. Clarke, MD
Vesselin Dimov, MD
Nemr S. Eid, MD
Shari M. Erickson, MPH
Alessandro Fiocchi, MD, FACAAI (SC)
Karen A. Freedle, MD, FACAAI
Curtis L. Hedberg, MD, FACAAI
Kirsi Jarvinen-Seppo, MD, PhD
John M. Kelso, MD, FACAAI
Tao T. Le, MD, MHS, FACAAI
Alnoor A. Malick, MD, FACAAI
Jennifer Mammen, MD
Bryan L. Martin, DO, FACAAI
Kathleen May, MD, FACAAI
Michael Nelson, MD, PhD, FACAAI
Myngoc T. Nguyen, MD, FACAAI
Richard A. Nicklas, MD, FACAAI
Maeve O'Connor, MD, FACAAI
Mark T. O'Hollaren, MD, FACAAI
Gurusher Panjrath, MD
Kavita Patel, MD
Joram S. Seggev, MD, FACAAI
Meagan Shepherd, MD
David R. Weldon, MD, FACAAI


Education Staff/Committee/Reviewers have no relevant financial relationships to disclose, except as may be listed above.

Available Credit

Accreditation Period

Course opens: 
10/15/2013
Course expires: 
10/14/2015

Price

Cost:
$0.00
Please login or create an account to take this course.